期刊文献+

钆塞酸二钠增强MRI评估全肝及各肝段肝功能 被引量:7

Gd-EOB-DTPA enhanced MRI in assessing whole liver and segmental liver function
下载PDF
导出
摘要 目的探讨钆塞酸二钠(Gd-EOB-DTPA)增强MRI评估肝功能正常者及肝功能受损患者肝脏储备功能。方法将99例乙型肝炎肝硬化肝功能异常者分为Child-Pugh A级(Child-Pugh A级组;n=48)、B级(Child-Pugh B级组;n=40)、C级(Child-Pugh C级组;n=11),以21例无慢性肝病肝功能正常者为肝功能正常组(n=21)。行Gd-EOB-DTPA增强MRI,于注射对比剂后3min、10min、20min图像计算全肝及各肝段相对强化程度(RE),比较不同肝功能分组间、各肝段间(S1~S8)肝脏RE的差异。结果增强后3min、10min、20min,Child-Pugh A级、B级、C级组与肝功能正常组间全肝RE和各肝段RE总体差异均有统计学意义(P均<0.05)。增强后3 min、10 min、20 min,肝功能正常组及Child-Pugh A级组各肝段间RE差异均有统计学意义(P均<0.05),Child-Pugh B级组增强后10min、20min和Child-Pugh C级组增强后20min各肝段间RE差异有统计学意义(P均<0.05)。结论Gd-EOB-DTPA增强MRI可准确评估全肝及各肝段的功能。 Objective To investigate the value of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid(Gd-EOBDTPA)enhanced MRI in assessing liver reserve function in patients with normal liver function and abnormal liver function.Methods Totally 99 hepatitis B cirrhosis patients with abnormal liver function were classified into the following three groups,i.e.Child-Pugh A group(n=48),Child-Pugh B group(n=40),Child-Pugh C group(n=11),while 21 patients without chronic liver disease were taken as normal liver function group.All patients underwent Gd-EOB-DTPA enhanced MRI.At 3 min,10 min and 20 min after intravenous administration of Gd-EOB-DTPA,the relative enhancement(RE)of whole liver and liver segments(S1—S8)was calculated,and the differences of liver RE were compared among different liver function groups and liver segments.Results At 3 min,10 min and 20 min after intravenous administration of GdEOB-DTPA,the differences of whole liver RE and segmental liver RE among the Child-Pugh A group,Child-Pugh B group,Child-Pugh C group and normal liver function group were statistically different(all P〈0.05).At 3 min,10 min and 20 min after injection,RE of normal liver function group and Child-Pugh A group was significantly different among different liver segments(S1—S8).At 10 min and 20 min after injection,RE of Child-Pugh B group was significantly different among different liver segments,while at 20 min after injection,RE of Child-Pugh C group was significantly different among different liver segments.Conclusion Gd-EOB-DTPA enhanced MRI can accurately assess whole liver and segmental liver function.
作者 张继云 陆健 张学琴 张涛 姜吉锋 ZHANG Jiyun;LU Jian;ZHANG Xueqin;ZHANG Tao;JIANG Jifeng(Department of Radiology,the Third People's Hospital of Nantong,Nantong 226006,China)
出处 《中国医学影像技术》 CSCD 北大核心 2018年第6期879-883,共5页 Chinese Journal of Medical Imaging Technology
基金 南通市市级科技计划(MS22015073)
关键词 肝功能 磁共振成像 对比剂 钆塞酸二钠 Liver function Magnetic resonance imaging Contrast media Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
  • 相关文献

参考文献6

二级参考文献80

  • 1Meng-Su Zeng,Hui-Yi Ye,Liang Guo,Wei-Jun Peng,Jian-Ping Lu,Gao-Jun Teng,Josy Breuer,Yi Huan,Ping Li,Jian-Rong Xu,Chang-Hong Liang.Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients:a multicenter,open-label,phase Ⅲ study[J].Hepatobiliary & Pancreatic Diseases International,2013,12(6):607-616. 被引量:40
  • 2虞积耀,崔金才,主译.消化系统肿瘤病理学和遗传学.北京:人民卫生出版社,2006,124-128.
  • 3Fan ST. Liver functional reserve estimation : state of the art andrelevance for local treatments: the Eastern perspective. JHepatobiliary Pancreat Sci ,2010,17 : 380-384.
  • 4Kim T, Murakami T,Hasuike Y,et al. Experimental hepaticdysfunction : evaluation by MRI with Gd-EOB-DTPA. J MagnReson Imaging,1997,7 : 683-688.
  • 5Ryeom HK,Kim SH,Kim JY,et al. Quantitative evaluation of liverfunction with MRI using Gd-EOB-DTPA. Korean J Radiol, 2004 ,5: 231-239.
  • 6Yamada A, Hara T, Fujinaga Y, et al. Quantitative evaluation ofliver function with use of gadoxetate disodium-enhanced MRimaging. Radiology,2011 ,260 : 727-733.
  • 7Van Beers BE,Pastor CM,Hussain HK. Primovist,Eovist: what toexpect. J Hepatol ,2012 ,57 ; 421-429.
  • 8Morris-Stiff G, Gomez D, Prasad R. Quantitative assessment ofhepatic function and its relevance to the liver surgeon. JGastrointest Surg 12009 ,13: 374-385.
  • 9Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology, 2005,42(5) : 1208-1236.
  • 10Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology, 2011,53(3) : 1020-1022.

共引文献88

同被引文献59

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部